Study Seeks Participants Diagnosed with Type 1 Diabetes to Test a New Medication that May Assist in Preventing the Development of Type 1 Diabetes in Future Generations.


We are currently seeking volunteers who are diagnosed with Type 1 Diabetes and who have at least one particular gene (DQ8) which is known to predispose a person to the development of diabetes. The gene (DQ8) is present in roughly 60% of people diagnosed with Type 1 Diabetes. Participants MUST be between the ages of 18 – 45 years old.

This is a study of an investigational medication that may help in preventing the development of Type 1 DM in future generations who have this same gene (DQ8). This study will hopefully show a successful binding of the medication to this gene in blood samples of Type 1 Diabetes patients who participate.  This investigational medication is not a cure for Type 1 Diabetes and should not affect your diabetes control.

All participants will pre-screen to test if they are positive for this gene, DQ8. If a participant tests positive, they may then participate in the full study.

After testing positive, participants will be randomly assigned to one of two groups (investigational medication or placebo). 80% of all study participants will receive the investigational medication, 20% will receive placebo. Participants will take the oral medication or placebo for a 3-week dosing period. Participants take the medication 1-2 times daily (depending on the dose and day).

Please contact us for further details by filling out this volunteer form below or calling us at 1-888-478-8343.